Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery

Last updated: April 15, 2025
Sponsor: Branch Office of "Hadassah Medical Ltd"
Overall Status: Active - Recruiting

Phase

N/A

Condition

Breast Cancer

Ductal Carcinoma In Situ (Dcis)

Treatment

Implant-based breast reconstruction using polytetrafluoroethylene mesh

Implant-based breast reconstruction using Allogeneic dura mater graft

Clinical Study ID

NCT06931548
BREAST-ONE
  • Ages > 18
  • Female

Study Summary

There is currently no consensus on the "gold standard" for Implant-based Breast reconstruction. In the United States, more than half of all breast reconstructions are performed using acellular dermal matrix (ADM). However, based on the findings of literature and systematic reviews, it can be cautiously said that synthetic meshes cause fewer complications with comparable aesthetic results and low cost. In our study, we propose using polytetrafluoroethylene (PTFE) mesh in implant-based breast reconstruction. This material has previously proven itself in cardiovascular, maxillofacial and neurosurgery, hernioplasty and as a suture material. Allogeneic dura mater, which has demonstrated comparable results in breast reconstruction with the literature, will be used as a comparison. The purpose of this study is to evaluate the efficacy and safety of a porous, non-biodegradable, synthetic polytetrafluoroethylene mesh for implant-based breast reconstruction in patients diagnosed with breast cancer. An allogeneic dura mater technique will be used as a control.

Patients eligible for this study are classified according to the National Comprehensive Cancer Network (NCCN) guidelines as having stage 0-2 breast cancer.

The primary questions this study aims to answer are:

  • What are the rates of major and minor complications associated with these techniques. Major complications will be defined as complications leading to reoperation.

  • How effective are PTFE mesh and dura in maintaining the inframammary fold and implant projection after breast reconstruction?

  • What is the patient satisfaction rate with the surgical results?

Patients will be randomly assigned to the study but will know which technique will be used in their particular case. Patients included in this study will undergo subcutaneous mastectomy or skin-sparing mastectomy using standard techniques with simultaneous implantation using PTFE mesh or allogeneic dura mater graft. In our opinion, the mesh and graft will stabilize the projections of the inframammary fold and breast implant.

After the surgery, all minor and major complications will be recorded for 6 months. For this, both physical examination and radiological diagnostic methods will be used, including breast ultrasound and MRI with contrast. Revision surgeries will be performed if necessary.

Projections of the inframammary fold and breast implant will also be measured in order to determine the effectiveness of the compared techniques.

Patients will be asked to complete the BREAST-Q Version 2.0© Reconstruction Module questionnaire to determine satisfaction with the surgical outcome.

The results of the study will help the professional community to determine the most effective method of Implant-based Breast reconstruction and will be published in peer-reviewed scientific journals.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • White women;

  • Breast cancer stage 0-II;

  • Indications for breast reconstruction;

  • Consent to participate in the study and photographic documentation.

Exclusion

Exclusion Criteria:

  • Non-white women;

  • Breast cancer stage III-IV;

  • Tubular breast;

  • Mental and cognitive health disorders;

  • Failure to comply with recommendations in the postoperative period (prematurephysical activity, not wearing compression underwear, missing scheduled visits,refusal of photo documentation);

  • Patient refusal to participate in the study at any stage.

Study Design

Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Implant-based breast reconstruction using polytetrafluoroethylene mesh
Phase:
Study Start date:
March 01, 2022
Estimated Completion Date:
February 28, 2026

Connect with a study center

  • The Branch of Hadassah Medical LTD

    Moscow, Skolkovo Innovation Center 121205
    Russian Federation

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.